Request for Contact Hours 2017

Similar documents
NURSING LEADERSHIP IMPACTING CHANGE

League of Intravenous Therapy Education Vascular Access Network 2016 Annual Educational Conference

2014 Partnership in Prevention Award. November 21, :00-1:00PM EST. Introduction

Technology Innovations in Vascular Access

How Do We Choose Optimal PIV Sites? Objectives. Good Vein, Bad Vein NIR & Choosing the Best IV Access Site. INS Site Choice Advice Key Points

THE JOURNEY TO CLINICAL INDICATION: TIME TO MOVE THE NEEDLE

21 st Century Health Care Consultants

Objectives. Vessel Health and Preservation: Disclosure. Ms. Moureau has disclosed the following: Angiodynamics, Genentech

Arrow Vascular Clinical Education

BRINGING THE PERIPHERY INTO FOCUS

Making Evidence-based Clinical Decisions. Paul L. Blackburn, BSN, MNA, RN, VA-BC

Gayle Kay Coulter, RN, CRNI, VA-BC

Expanding the Role of a Vascular Access Team:

WHY IMPLEMENT CENTRAL LINE INSERTION BUNDLES

Peripheral IVs: THINK BIG. LOOK SMALL. Michelle DeVries MPH, CIC. Senior Infection Control Officer Methodist Hospitals Gary, Indiana

Joint Commission NPSG 7: 2011 Update and 2012 Preview

Describe the impact of CLABSI on patients and their families. Discuss three methods of reducing CLABSIs

Exemplary Professional Practice CARE DELIVERY SYSTEM(S)

CMS and NHSN: What s New for Infection Preventionists in 2013

PICCs. Vascular access is the cornerstone in the. It s all about. Vascular safety:

Arrow Vascular Clinical Education

F E B R U A R Y 2 8, S C O T T F L A N D E R S, M D V I N E E T C H O P R A, M D

B.S.N., M.S., CRNI, CNSN

Patricia Church, MSN, RN, PCNS-BC, CPON Bernice Mowery, PhD, PNP, RN

APIC Election 2017 Results

NADONA Infection Prevention and Control (IPAC) Certificate of Mastery Program Information Packet

HRM CERTIFICATE PROGRAM

DEVELOPMENT OF A DIFFICULT VENOUS ACCESS PATHWAY

APIC 2018 Election Results

Reducing Infection Risks Related to Vascular Access Devices: Competency and Training

Does Certification in Vascular Access Matter? An Analysis of the PICC1 Survey

HCA Infection Control Surveillance Survey

APIC Fellow. In May 2016, I was notified that I had been selected to be in the. Becoming an

Objectives. Salem Health 11/1/2017. A Lean Journey to Reducing Central LineAssociated Bloodstream Infection (CLABSI) Rates

The 2016 INFUSION THERAPY STANDARDS. The Infusion Nurses Society (INS) publishes evidence-based practice 1.5

Infection Prevention. Fundamentals of. March 21-23, 2017 Oregon Medical Association Portland, OR. oregonpatientsafety.org

Central Venous Access Devices (CVADs)

Reducing Infections and Improving Engagement St. Luke's Nephrology Associates. Contact Information: Robert Gayner, M.D., FASN

Hospital-Acquired Infections Prevention is in Your Hands. Rachel L. Stricof

Using Care Bundles to Reduce Catheter Associated Blood Stream Infections in the NICU. Dr David Ng Paediatric Medical Officer Sarawak General Hospital

Making Dialysis Safer for Patients Coalition

Recommendations for Improving Safety Practices With Short Peripheral Catheters

4/30/2012. Disclosure. Housekeeping. The Role of the Infection Preventionist on the Value Analysis Committee. Boyd Wilson

Dr Cathryn Louise Murphy RN B. Photog MPH CIC PhD

Speaker Biographies Arjun Srinivasan, MD (CAPT, USPHS) Benjamin Chan, MD, MPH, Michael Calderwood, MD, MPH, FIDSA,

HAI Peer Learning Network Peer Sharing Event. Topic: CLABSI Prevention. Nov. 28, Place picture here

Healthcare-Associated Infections

THE DNP AT THE UNIVERSITY OF

PATRICIA K. LAFFERTY, PhD, RN

GLOBAL PEDIATRIC Clinical Skills Week October 23 27, 2017

"Risky Business", Staff -Patient Safety Newsletter

The Nurse s Role in Preventing CLABSI

Misconceptions About Peripheral Intravenous Catheter Complications Rate Based on Insertion Settings: A Comprehensive Literature Review

Your gateway to 300+ associations in the National Healthcare Career Network

Critical Care Medicine Clinical Privileges

2017 Gardner Foundation. Scholarship Program

Central Line Bloodstream Infections (CLABSI) Prevention Outside the ICU

Implementation Guide for Central Line Associated Blood Stream Infection

Translating Evidence to Safer Care

Role of the C-Suite in High Reliability Antimicrobial Stewardship

The dirty truth about IV access points. For full text documents, please contact customer support

How to Add an Annual Facility Survey

EXHIBIT 1 ACTIVELY RECRUITED POSITIONS LIST (As of 03/16/18)

NADONA TeamSTEPPS Certificate of Mastery Program Information Packet

INDIANA UNIVERSITY SCHOOL OF NURSING

Example 1: Non-Nutritive Suck and Cue-Based Feedings Instead of Scheduled Feedings in the Newborn Intensive Care Unit

The Role of the Licensed Practical/Vocational Nurse in Infusion Therapy in Long-Term Care

IMPLEMENTATION OF A DIFFICULT VENOUS ACCESS (DiVa) PATHWAY

Meeting the NEW RCN Standards for Infusion Therapy in practice

Patient Safety: 10 Years Later Why is Improvement So Hard? Patient Safety: Strong Beginnings

See Policy #1302 (Nursing Student Privileges and Limitations) for full details. Central Line dressing care, declotting and discontinuation may ONLY

Einstein Healthcare Network. Georgetown University School of Nursing & Health Studies. Nursing Career Day 2012 / Employers

Making PICCs Safer What We Know; What We Don t Know; What We Need to Know

CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)

HRET HIIN MDRO Taking MDRO Prevention to the Next Level!

Key prevention strategies for MRSA bacteraemia: a case study. Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta

Advancing IV Therapy: national update and developments

Transitioning OPAT (Outpatient Antibiotic Therapy) patients from the Acute Care Setting to the Ambulatory Setting

Organizational Structure Ossama Rasslan

IT TAKES A VILLAGE TO IMPLEMENT CATHETER ASSOCIATED URINARY TRACT INFECTION (CAUTI) PREVENTION

Objectives 31/07/2014. Peripheral IV Catheters: If clinically indicated replacement doesn t work, what will? Financial Disclosures

Demographics. 1. How many years of experience do you have as an epidemiologist? 2. What is the highest degree you have obtained?

Adopting Best Practice for Infusion Teams

Chasing Zero Infections Coaching Call CLABSI: Reducing PICC and Central Line Utilization to Eliminate Bloodstream Infection April 10, 2018

1.2 billion ambulatory care visits in US: physician offices, outpatient hospital and ED

Organization: Sinai Hospital of Baltimore

Yale New Haven Health System Center for Healthcare Solutions

APPLICATION. Thank you for your interest in applying for the APIC Program of Distinction.

Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) Vision: Healthcare without infection

VAD Guidelines for Home Infusion: Creating a Resource. Care for Pediatric Patients 4/12/2012

Running head: EBN & CAUTIS 1

Institution Degree Year University of Texas Houston Doctorate of Nursing Practice 2012 Health Science Center School of Nursing Houston, TX

The W.I.S.E Tool for Assessment of Short Term PICC Use

I Have my BSN-Now What?

Peripheral intravenous catheter performance: investigating peripheral intravenous catheter dwell times

Leadership Engagement in Antimicrobial Stewardship

Interprofessional Education Seminar Series: A Certificate Program for Health Care Providers. Basic Education of Selected Healthcare Professionals

2014 ONS Distinguished Researcher Award Susan C. McMillan

4/28/17. New Jersey Antimicrobial Stewardship Learning Action Collaborative. Antimicrobial Stewardship Efforts in New Jersey. Update May 10, 2017

Practice Guideline: Approval Date: May 11, 2017

Transcription:

Request for Contact Hours 2017 Demographic Information Educational Event: LITEVAN Annual Educational Meeting, April 20-21, 2017 Title of Event: A Bright Future for Vascular Access Sessions: 12 session consisting of 12 hours of continuing education Planning Committee: The planning committee consists of the LITEVAN Board of Directors: Anne Marie Parry, Dawn Thomas, Dave Ingram, Gloria Aquillo, and Peggy Pearl Faculty/Presenter/Author Name Joan Hebden Gregory Schears Nancy Moreau Cheryl Gordon Michelle (Chellie) DeVries Vineet Chopra Eddie Korycka Dean Parry Jim Lacy Laura Fisk Credentials RN, MS, CIC MD BSN, CRNI, CPUI, VA-BC CRNI MPH, CIC MD RN RPh BSN, RN, VA-BC N/A

Presenter Course Title Objectives Length Joan Hebden Chlorhexidine Gluconate for the Prevention of Central Line-Associated Bloodstream Infections 1. Define the mechanism of action of chlorhexidine gluconate (CHG) 2. Understand the two modes of bacterial pathogenesis into the bloodstream from intravascular devices 3. Define the uses of CHG to prevent central line-associated bloodstream infections (CLABSI) 4. State the current CDC recommendations for the use of CHG Gregory Schears Nancy Moreau Placing PIV Catheters Under the Light Using NIR Technology Midline Indications and Usage Cheryl Gordon Vascular Access Assessment in the ICU to prevent CLABSI 1. Describe how NIR imaging systems can be used as a screening tool for vascular pre-assessment. 2. Assess vasculature with NIR identifying valves, bifurcations and tortuosities. 3. Distinguish good vs. poor vascular access targets. 1. Define and describe midlines and their advantages and benefits. 2. Describe indications and usage specific to midlines versus PICCS/CVADS. Discuss challenges associated with central venous access in ICU Describe an Algorithm for Catheter Selection Compare Risks and Complications for different central venous catheters Chellie DeVries Peripheral IVs: Think Big, Look Small ( the impact PIVs have with Review data surrounding risks associated with Peripheral IVs (PIVs)

the Affordable Care Act, CLABSI rates, and Cost) Discuss how care and maintenance of PIVs relates to the changing healthcare landscape Identify strategies to lessen risks associated with PIV complications and sequelae Dean Parry Biosimilars Understand how the FDA had defined Bioequivalence Discuss the potential impact of bioequivalent products on the pharmaceutical market Review State and Nation Laws concerning Bioequivalent products. Vineet Chopra Are PICCs the CVC of the Future? Eddie Korycka You CAN Get There From Here; Identify Your Path to Optimizing Your Vascular Access Program Nancy Moreau CLABSI-What Are We Missing? 1. Discuss the evidence available comparing PICCs to other central venous catheters. 2. Review data regarding current PICC practices from the Michigan Hospital Medicine Safety Study. 3. Describe how the Michigan Appropriateness Guide to Intravascular Catheters (MAGIC) may inform the selection of an appropriate vascular access device. 1. Explore individual and organizational approaches to vascular access educational needs. 2. Identify current standards, best practices and regulatory bodies that should drive our educational approach and clinical performance. 3. Develop a Go Forward plan for improving practice and helping your organizations optimize their vascular access programs. 1. Describe purpose of any infection prevention process in effectively reducing infections and risk to patients in exploring some of the possibilities for What is Missing.

Dean Parry Jim Lacy Opioid Crisis in PA and Across the Country Vessel Health and Preservation 2. Evaluate common breaks in aseptic technique for needleless connector access along with published evidence of compliance, levels of intraluminal contamination, and disinfection practices. 3. Outline eight recommendations and levels of evidence for improving disinfection with needleless connectors. Understand the impact of the Opioid Crisis in Pennsylvania and across the country Discuss current regulatory and legislative changes implemented to combat the opioid crisis Discuss the role of health care providers in dealing with the Opioid Crisis Gain Perspective on the historical and current use of opioids 1. Describe the use of the UK Vessel Health and Preservation Framework for appropriate device selection 2. List 3 key principles of vascular access 3. Recognize the risks associated with vascular access 1 hour Laura Fisk I m Just a Mom! Become familiar with a parent s story of a child with a lifelong disease Recognize the positive and negative experiences of various central lines in a child Identify ways to improve education and communication between caregivers and nursing staff 1 hour

Biography of Each Presenter Faculty/Presenter/Author Name Joan Hebden Gregory Schears Joan Hebden RN, MS, CIC received her baccalaureate and master s degrees from the University of Maryland School of Nursing. Her clinical background includes general medicine, oncology and cardiothoracic intensive care. Currently, she is an independent infection prevention consultant. Previously, she was employed by Wolters Kluwer Health as a clinical program manager for the company s surveillance application and served as the Director of Infection Prevention and Control for 28 years at the University of Maryland Medical Center in Baltimore, Maryland. An accomplished practitioner, Ms. Hebden has presented at national epidemiology conferences, participated in research regarding the transmission of multi-drug resistant bacteria, contributed chapters on infection control to nursing resource texts, and published in medical and infection control journals. She is certified in infection control through the Certification Board of Infection Control and Epidemiology, is an active member of the Society for Healthcare Epidemiologists of America and the Association for Professionals in Infection Control and serves as a section editor and reviewer for the American Journal of Infection Control. Dr. Schears is a pediatric Intensivist and anesthesiologist with a long standing interest in reducing patient complications and improving our approach to vascular access. He did his pediatric residency at St. Louis Children's Hospital, his anesthesia residency, pediatric anesthesia fellowship and pediatric critical care fellowship at John's Hopkins hospital. He worked at the Children's Hospital of Philadelphia for 5 years and was recruited to the Mayo Clinic in 2001 to head the ECMO service. There he is the physician liaison to the nurse led PICC team, Medical Director of the ECMO Service and Co-Director of the Congenital Heart Unit. He is on the editorial board for JAVA and serves on the AVA Board of Directors as Treasurer and recently chaired AVA s strategic planning task force. He is very active with product development to help reduce vascular access complications

and has given hundreds of presentations locally, regionally, nationally and internationally. Nancy Moreau Nancy Moureau is an internationally recognized speaker and expert in the field of peripherally inserted central catheters and vascular access practice. A nurse for more than 30 years Nancy continues her clinical work as staff member on the PICC/IV team at Greenville Memorial Hospital in Greenville, SC. As the owner and CEO of PICC Excellence, Nancy creates online educational programs and works with companies to provide education to clinicians. Nancy is constantly involved with research and literature analysis, now working in conjunction with Griffith University and the AVATAR group Alliance for Vascular Access Teaching and Research as an adjunct associate professor and a doctoral candidate. Nancy takes on many projects and most recently chaired the International Consensus Forum for the World Congress of Vascular Access (WoCoVA) to establish Standard Minimal Education Requirements for Central Venous Access Devices. Nancy has established the only registered PICC Certification process, Certified PICC Ultrasound Inserter, where those who meet and maintain qualifications gain the credentials CPUI. She is happy to act as a resource and is available by email on your handouts or through the website www.piccexcellence.com Cheryl Gordon Cheryl has been a nurse for 20 years and has spent the last 14 years in the Vascular Access Specialty. She obtained her Certified Registered Nurse Infusion from INS in 2005 and received her Vascular Access- Board Certification from the Association of Vascular Access in 2010. Her background is in Critical Care where she worked in both Trauma ICU and Surgical ICU. Currently, she is a Clinical Specialist for Bard Access Systems and in that role provides on-site education for PICC line placement, new PICC technologies, Ultrasound Guidance and Midline insertion across a 7 state region. She has been a speaker for local and regional nursing conferences on topics including Ultrasound Guided PIV insertions, Midlines, PICCs, and CLABSI reduction strategies. She most recently presented internationally on PICC practices and strategies. Chellie DeVries Chellie has over 20 years of experience in infections control and hospital epidemiology spanning university, federal and community healthcare systems. Her background is hospital and molecular epidemiology, and her passion is raising awareness around PIVs. Chellie has traveled throughout the country speaking to local, regional and national AVA, INS, APIC and AACN chapters, and

Vineet Chopra last year brought the message to Saudi Arabia, Kuwait and Kenya. Chellie was a reviewer from the 2016 INS Standards and recently authored the chapter on Intravascular Device Associated Infections for the International Federation of Infection Control Text. Dr. Chopra is an Asst Prof of Medicine and Research Scientist at the University of Michigan School of Medicine and the Ann Arbor VA Medical Center. A career hospitalist, Dr. Chopra s research is dedicated to improving the safety of hospitalized patients through prevention of hospital-acquired complications. His work focuses on identifying and preventing complications such as infection and thrombosis associated with peripherally inserted central catheters. Dr. Chopra is funded by a Career Development Award from the Agency of Healthcare Research and Quality and has received grant support from the National Institute of Aging, the Blue Cross/Blue Shield Foundation of Michigan and the American Heart Association. Eddie Korycka Dean Parry He is the recipient of numerous research awards including the 2016 Jerome W. Conn Award for Outstanding Research by Junior Faculty, 2016 Society of Hospital Medicine Excellence in Research Award, 2014 McDevitt Award for Research Excellence, and the 2014 Society of Hospital Medicine Young Investigator Award. He has published over 100 peer-reviewed papers and is Associate Editor at the American Journal of Medicine and the Journal of Hospital Medicine. Dr. Chopra is a voting member of the Center for Disease Control s Healthcare Infection Control Practice Advisory Committee (HICPAC). Eddie has been a nurse since 1989. He has held positions in the emergency department, as a manager in med/surgery and as a staff nurse and manager in home infusion. Eddie owned his own infusion consulting company for over 10 years. He has been an active member of INS and AVA. He is currently the Clinical Education Director at Centurion Medical Products. Having practiced the specialty of infusion therapy and vascular access in many settings, he looks forward to sharing his expertise and gaining knowledge from his colleagues wherever he speaks. Mr. Parry, RPh graduated from Philadelphia College of Pharmacy and Science in 1981 with a BS in Pharmacy. After graduation he worked as a pharmacist at Geisinger Medical Center, in Danville, PA. In January 1985, he accepted a position as Chief Pharmacist at Macha Mission Hospital in Choma, Zambia, Africa. Mr. Parry

Jim Lacy Laura Przybysz was deeply involved in the leadership of the Churches Medical Association of Zambia and also in the area of research related to the treatment of malaria. He has co-authored several research articles related to the treatment of malaria. On his return the United States in 1995, he again accepted a position at Geisinger Medical Center and has been actively involved in various areas including health care redesign projects in the late 1990s and in the development of various pharmaceutical care programs for the organization. For 15 years Mr. Parry was responsible for ambulatory and acute care clinical pharmacy programs throughout the health system. During that time he worked closely with health system leadership in the development of processes and guidelines for appropriate utilization of medications. In his current role as AVP, Clinical Informatics, we is responsible for bridging the clinical needs of the organization with the electronic health record, monitoring changes made for impact on outcomes and utilization for both pharmacy and supply chain. Jim Lacy has over 30 years of experience in nursing with a focus on adult, pediatric and neonatal critical care, home infusion therapy, infusion nursing, and vascular access. Over the last 20 years Jim has worked in the medical device industry as a Clinical Marketing Manager, Clinical Director and consultant with focus on management and creation of education and training programs, development of clinical educators and trainers, new product design, research, marketing and clinical customer support. Jim has presented at both sponsored and invited educational offerings throughout the United States and internationally. He has published original articles related to HIV disease, infusion therapy, vascular access, and vascular access program development. He was the recipient of the 2011 Suzanne LaVere Herbst Award for Excellence in Vascular Access, awarded by AVA for lifetime contributions to the art and science of vascular access. He has served on the Board of Directors of the Association for Vascular Access (AVA) and served as the 2013-2014 President of the Association and is a former Trustee of the Oley Foundation. Laura Przybysz, mom to a five year old named Nolan. Nolan has mitochondrial disease and is TPN dependent. After spending the past five years entrenched in the medical world, I have recently started pursuing an RN at CCAC.